| News
MTIP using new fund to invest in innovative companies
06.04.2021
The Basel-based firm MTIP AG specializes in investments in HealthTech companies. A total of 130 million euros has already been raised for a new fund. This capital will be invested in companies operating in the fields of digital health and connected medical devices.

Private equity firm MTIP invests in digital health, combining innovation and medical practice (img: MTIP)
MTIP AG has now raised a total of 130 million euros for its fund MTIP FUND II, SCSp. The first closing has now been completed, details of which can be found in a press release issued by MTIP. The target volume amounts to 200 million euros, with the fund serving to facilitate investments in companies operating in areas such as digital health and connected medical devices. In addition to being “primarily” based in Europe, it is also essential that the companies offer “differentiated” solutions. According to Christoph Kausch, Managing Partner at MTIP, the total of 130 million euros means that MTIP has “overachieved our expectations”. While he also describes the first closing as “an enormously important milestone in our company history”.
The total of 130 million euros raised so far has been sourced from various investors. Moreover, MTIP works with the European Investment Fund (EIF) as an anchor investor. “MTIP’s fund strategy fits with EIF’s ambition of financing the vital growth segment of the European Venture Capital ecosystem, which is largely underfunded and overly dependent on non-European investors for larger investments”, comments Alain Godard, Chief Executive of EIF, in the press release.
The fund has already invested in three companies. The first, Oviva, is active in the area of nutrition consulting, while the second, Trialbee, focuses on patient recruitment for clinical trials, and the third, Koa Health, develops digital treatments for mental illnesses. Kausch believes that these and further investments will create “strong momentum towards the final close”.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read MoreUniversity of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read MoreRami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read MoreBasel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....
Read MoreRoche and Novartis among global leaders for research spending
In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...
Read MoreRoche to found Institute for Human Biology
Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...
Read More